Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 0 | -13 | 15,000 |
| Gross Profit | N/A | N/A | N/A | -13 | 15,000 |
| Operating Expenses | 1,212 | 4,061 | 5,653 | 5,822 | 3,023 |
| Operating Income | -1,212 | -4,061 | -5,653 | -5,835 | 11,977 |
| Other Income | 672 | 5,890 | -4,289 | -3,315 | -796 |
| Pre-tax Income | -540 | 1,829 | -9,941 | -9,150 | 11,181 |
| Income Tax | -35 | -35 | -35 | -267 | -81 |
| Net Income Continuous | -505 | 1,864 | -9,907 | -8,884 | 11,262 |
| Net Income | $-505 | $1,864 | $-9,907 | $-8,884 | $11,262 |
| EPS Basic Total Ops | -0.09 | 0.41 | -4.41 | -4.93 | 6.55 |
| EPS Basic Continuous Ops | -0.09 | 0.41 | -4.41 | -4.93 | 6.55 |
| EPS Diluted Total Ops | -0.09 | -0.77 | -4.41 | -4.37 | 6.55 |
| EPS Diluted Continuous Ops | -0.09 | 0.41 | -4.41 | -4.93 | 6.55 |
| EPS Diluted Before Non-Recurring Items | -0.09 | -0.77 | -4.41 | -5.79 | 6.55 |
| EBITDA(a) | $-1,046 | $-3,895 | $-5,487 | $-5,669 | $12,143 |